General MedicationsNASALStandard
FLUNISOLIDE
FLUNISOLIDE
Standard Dose
0.025MG/SPRAY
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview FLUNISOLIDE is listed in Drugs@FDA under application 207802 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient FLUNISOLIDE Form and strength SPRAY, METERED;NASAL - 0.025MG/SPRAY Sponsor RICONPHARMA LLC Submission history Latest submission status date: 2022-06-16 00:00:00.
Structured Monograph
Clinical summary
Approval overview FLUNISOLIDE is listed in Drugs@FDA under application 207802 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient FLUNISOLIDE Form and strength SPRAY, METERED;NASAL - 0.025MG/SPRAY Sponsor RICONPHARMA LLC Submission history Latest submission status date: 2022-06-16 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.